Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Avidity Biosciences, Inc. company logo
Avidity Biosciences, Inc. logo

Avidity Biosciences, Inc. (RNA)

Summary

As of today, RNA price is $14.75, down -79.74% on
RNA price is currently -79.81% below its historical high of $73.06 set on
RNA current market cap is $2B, down -36.42% year-over-year
RNA PE ratio is unknown
RNA current annual revenue is $18.76M, up +72.11% year-over-year
The next earnings release for RNA is on

Profile

Company profile for Avidity Biosciences, Inc. (RNA)
MetricValue
Full NameAvidity Biosciences, Inc.
TickerNASDAQ: RNA
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websiteaviditybiosciences.com
Employees391

Key Metrics

Avidity Biosciences, Inc. Key Details
MetricDateValue
Price$14.75
Price, 1D Change-79.74%
Market Cap$2B
-
PE Ratio-
Beta1.09
Revenue$19M
Revenue, 1Y Change+72.11%
EPS-$4.97
EPS, 1Y Change-72.11%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Avidity Biosciences, Inc. chart

Events

Avidity Biosciences, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

RNA Estimates
MetricDateValue
EPS-$4.97
EPS EstimateN/A-$4.92
EPS Est. ChangeN/A+1.03%
Revenue$18.76M
Revenue EstimateN/A$19.34M
Revenue Est. ChangeN/A+3.10%
Current Price$14.75
Price Target--
Price Tgt. Change--

🔒 Log In To Unlock Full Data

EPS

RNA EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$2.74-$2.91-6.08%
-$2.86-$2.89-1.09%
-$4.49-$4.97-10.62%
-$4.92N/A+1.03%
RNA EPS reported versus estimate values chart

Revenue

RNA revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$9.56M$9.56M0.00%
$9.75M$10.90M+11.76%
$18.36M$18.76M+2.16%
$19.34MN/A+3.10%
RNA revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

RNA Performance
MetricDateValue
Price, 1Y-49.28%
Price, 3Y-36.04%
Market Cap, 1Y-36.42%
Market Cap, 3Y+36.11%
Revenue, 1Y+72.11%
Revenue, 3Y+103.33%
EPS, 1Y-72.11%
EPS, 3Y-49.04%

🔒 Log In To Unlock Full Data

Technical Indicators

RNA Technical Indicators
MetricDateValue
Current Price$14.75
SMA 200$52.61
SMA 200 vs Price+256.66%
SMA 50$71.37
SMA 50 vs Price+383.90%
Beta1.09
ATR$4.45
14-Day RSI0.87
10-Day Volatility400.21%
1-Year Volatility109.20%

Dividends

RNA Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
$0.00
0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

RNA Income & Profitability
MetricDateValue
Revenue$18.76M
EPS-$4.97
Gross Profit$14.60M
Gross Margin77.87%
Operating Profit-$745.94M
Operating Margin-3,977.30%
Net Income-$684.63M
Net Margin-3,650.39%
EBITDA-$741.79M

🔒 Log In To Unlock Full Data

Financial Health

RNA Financial Health
MetricDateValue
Debt To Equity0.03
9.20
9.20
-
1
3.56

Valuations

RNA Valuations
MetricDateValue
PE Ratio-
118.50
1.32
-0.77
N/A-

Balance Sheet

RNA Balance Sheet
MetricDateValue
Book Value$1.69B
$1.70B
$1.96B
$1.80B
$269.45M
$195.45M
Total Debt$49.25M
$3.94M
$12.40M

Expenses

RNA Expenses
MetricDateValue
$703.39M
$760.55M
$4.15M
$0.00
$4.15M
$0.00
$0.00

Cash Flow

RNA Cash Flow
MetricDateValue
-$650.44M
-$38.04M
$850.99M
Capex$13.32M
-$663.76M

Recent analyst updates

RNA Recent analyst updates
MetricDateValue
Chardan Capital→
TD Cowen→
RBC Capital→
Chardan Capital→
Raymond James→
Needham→
Leerink Partners→
HC Wainwright & Co.→
Citigroup→
Bernstein→

Analyst sentiment

Sentiment over the past month
RNA analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
RNA institutional ownership distribution chart

Screeners with RNA

FAQ

  • What is the ticker symbol for Avidity Biosciences, Inc.?

    The ticker symbol for Avidity Biosciences, Inc. is NASDAQ:RNA

  • Does Avidity Biosciences, Inc. pay dividends?

    No, Avidity Biosciences, Inc. does not pay dividends

  • What sector is Avidity Biosciences, Inc. in?

    Avidity Biosciences, Inc. is in the Healthcare sector

  • What industry is Avidity Biosciences, Inc. in?

    Avidity Biosciences, Inc. is in the Biotechnology industry

  • What country is Avidity Biosciences, Inc. based in?

    Avidity Biosciences, Inc. is headquartered in United States

  • When did Avidity Biosciences, Inc. go public?

    Avidity Biosciences, Inc. initial public offering (IPO) was on June 12, 2020

  • Is Avidity Biosciences, Inc. in the S&P 500?

    No, Avidity Biosciences, Inc. is not included in the S&P 500 index

  • Is Avidity Biosciences, Inc. in the NASDAQ 100?

    No, Avidity Biosciences, Inc. is not included in the NASDAQ 100 index

  • Is Avidity Biosciences, Inc. in the Dow Jones?

    No, Avidity Biosciences, Inc. is not included in the Dow Jones index

  • When was Avidity Biosciences, Inc. last earnings report?

    Avidity Biosciences, Inc.'s most recent earnings report was on November 10, 2025

  • When does Avidity Biosciences, Inc. report earnings?

    The next expected earnings date for Avidity Biosciences, Inc. is March 2, 2026

Data Sources & References

  1. RNA Official Website www.aviditybiosciences.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1599901/000159990126000031/0001599901-26-000031-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599901/000159990126000031/0001599901-26-000031-index.htm
  4. RNA Profile on Yahoo Finance finance.yahoo.com/quote/RNA
  5. RNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rna